Novel Findings for the Development of Drug Therapy for Various Liver Diseases: Liver Microsomal Triglyceride Transfer Protein Activator May Be a Possible Therapeutic Agent in Non-Alcoholic Steatohepatitis

Journal of Pharmacological Sciences - Japan
doi 10.1254/jphs.10r14fm
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Pharmacological Society

Related search

Novel Findings for the Development of Drug Therapy for Various Liver Diseases: Genetic Variation in IL-28B Is Associated With Response to the Therapy for Chronic Hepatitis C

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2011English

Can Transient Elastography Be a Reliable Method for Assessing Liver Fibrosis in Non Alcoholic Steatohepatitis (NASH)?

Medical Ultrasonography
Nuclear MedicineRadiologyUltrasound TechnologyAcousticsUltrasonicsRadiologicalImaging
2013English

1. Fatty Liver and Non-Alcoholic Steatohepatitis

Internal Medicine
Internal MedicineMedicine
2007English

Microsomal Triglyceride Transfer Protein

2002English

Identification of a Novel Transcript and Regulatory Mechanism for Microsomal Triglyceride Transfer Protein

PLoS ONE
Multidisciplinary
2016English

Therapeutic Potential of Peroxisome Proliferator-Activated Receptor Modulation in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Nuclear Receptor Research
2017English

Liver Transplantation for Non-Alcoholic Steatohepatitis in Europe: Where Do We Stand?

Journal of Hepatology
Hepatology
2019English

Global Perspectives on Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Hepatology
MedicineHepatology
2019English

Non-Alcoholic Steatohepatitis: A Common Cause of Progressive Chronic Liver Injury?

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy